Back to News
Market Impact: 0.05
Nicox Announces NCX 470 NDA in China Accepted for Review
Source: GlobeNewswire
Healthcare & BiotechRegulation & Legislation
The article defines a PDUFA date as the FDA's target deadline to complete review and issue a decision on a New Drug Application under the Prescription Drug User Fee Act. It contains no company-specific drug, decision, financial magnitude, or market-moving update.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- USTR Greer tells EU that loan to Airbus threatens trade truce on aircraft financing
- Anthropic’s risk factors include the end of humanity, a feud with the Pentagon, and CEO Dario Amodei’s reputation
- Iran’s anti-negotiation hardliners turn against President Pezeshkian
- J&J's potential 'game-changer' drug — plus, what Microsoft's mass buyouts mean
- Anthropic publicly files for listing on the US stock market
- ‘Imposed significant financial harm’: 20 states join the FTC in suing Dollar General for ‘deceptive pricing practices’ despite ‘corporate knowledge’